Kit for pharmaceutical use

Details for Australian Patent Application No. 2004226326 (hide)

Owner The Procter & Gamble Company

Inventors Trombley, Kurt Franklin; Difabritus, Vincent Anthony; Van Der Geest, Stephanus Alexander Paulus; Cawthray, Richard James; Loughren, Ellen Mary

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2004226326

PCT Pub. Number WO2004/087038

Priority 60/457,865 26.03.03 US

Filing date 26 March 2004

Wipo publication date 14 October 2004

Acceptance publication date 17 April 2008

International Classifications

A61J 1/03 (2006.01) Containers specially adapted for medical or pharmaceutical purposes

A61J 7/04 (2006.01) Administering medicines orally

C12P 21/06 (2006.01) Preparation of peptides or proteins - produced by the hydrolysis of a peptide bond, e.g. hydrolysate products

Event Publications

13 October 2005 PCT application entered the National Phase

  PCT publication WO2004/087038 Priority application(s): WO2004/087038

17 April 2008 Application Accepted

  Published as AU-B-2004226326

14 August 2008 Standard Patent Sealed

18 February 2010 Assignment Registered

  The Procter & Gamble Company The patent has been assigned to Warner Chilcott Company, LLC

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004226327-Implantable medical device with beneficial agent concentration gradient

2004226324-Topical L-carnitine compositions